Explore more publications!
Healthcare Today Michigan
Submit Press Release

Healthcare Today Michigan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 10, 2025

City Beat News Recognizes Businesses for a Decade of Outstanding Customer Satisfaction
September 10, 2025

City Beat News Recognizes Businesses for a Decade of Outstanding Customer Satisfaction

Indeterminate EIN Presswire
The Talk Awards Recognizes Three Dental/Orthodontic Practices for Outstanding Patient Service and Satisfaction
September 10, 2025

The Talk Awards Recognizes Three Dental/Orthodontic Practices for Outstanding Patient Service and Satisfaction

Indeterminate EIN Presswire
HPU Celebrates Grand Opening of New Dental School Building
September 10, 2025

HPU Celebrates Grand Opening of New Dental School Building

Indeterminate GlobeNewswire
MJH Life Sciences® showcases Strategic Alliance Partner expertise while deepening relationships through Media Days
September 10, 2025

MJH Life Sciences® showcases Strategic Alliance Partner expertise while deepening relationships through Media Days

Indeterminate GlobeNewswire
Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray
September 10, 2025

Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray

Indeterminate GlobeNewswire
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
September 10, 2025

Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA

Indeterminate GlobeNewswire
Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate
September 10, 2025

Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate

Indeterminate GlobeNewswire
Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 10, 2025

Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Academy Calls for Evidence-Based Solutions in Response to MAHA Strategy Report
September 10, 2025

Academy Calls for Evidence-Based Solutions in Response to MAHA Strategy Report

Indeterminate GlobeNewswire
Keystone Place at Newbury Brook Senior Living Community Expands with 39 New Apartments, Launches Innovative Transitional Memory Care.
September 10, 2025

Keystone Place at Newbury Brook Senior Living Community Expands with 39 New Apartments, Launches Innovative Transitional Memory Care.

Indeterminate GlobeNewswire
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
September 10, 2025

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
September 10, 2025

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions
September 10, 2025

LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions

Indeterminate GlobeNewswire
Revolution Medicines Shares New Clinical Results Supporting Initiation of RASolute 303, a Global Phase 3 Registrational Trial of Daraxonrasib in First Line Metastatic Pancreatic Ductal Adenocarcinoma
September 10, 2025

Revolution Medicines Shares New Clinical Results Supporting Initiation of RASolute 303, a Global Phase 3 Registrational Trial of Daraxonrasib in First Line Metastatic Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 10, 2025

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Design Therapeutics Appoints Justin Gover to Board of Directors
September 10, 2025

Design Therapeutics Appoints Justin Gover to Board of Directors

Indeterminate GlobeNewswire
Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers
September 10, 2025

Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers

Indeterminate GlobeNewswire
New Book, A Legacy of Hope, Traces Four Decades of Faith and Vision Behind Leading Pediatric Health Center
September 10, 2025

New Book, A Legacy of Hope, Traces Four Decades of Faith and Vision Behind Leading Pediatric Health Center

Indeterminate GlobeNewswire
Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
September 10, 2025

Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

Indeterminate GlobeNewswire
[Latest] Blockchain in Healthcare Market Size to Hit USD 61,111 Million at a CAGR of 71.10% by 2034 - Report by Zion Market Research (ZMR)
September 10, 2025

[Latest] Blockchain in Healthcare Market Size to Hit USD 61,111 Million at a CAGR of 71.10% by 2034 - Report by Zion Market Research (ZMR)

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions